SEI Investments’s Aurinia Pharmaceuticals AUPH Stock Holding History
Bought
Maintained
Sold
Other funds holding AUPH
TCM
NMC
SEI Investments's AUPH Position: Q2 2026 in Review
SEI Investments increased its Aurinia Pharmaceuticals (AUPH) stake by 13% in Q2 2026, buying an estimated $43.3K and bringing the position to 23,356 shares worth $396K. The position accounts for ﹤0.01% of the portfolio, ranked #2740.
SEI Investments first reported a position in AUPH in Q3 2025 and has held it in 4 quarters since. The position peaked at $480K in Q3 2025. 282 funds tracked by Wall St. Rank hold AUPH as of Q2 2026.
- SEI Investments held 23,356 shares of Aurinia Pharmaceuticals worth $396K as of Q2 2026.
- SEI Investments bought 2,711 Aurinia Pharmaceuticals shares in Q2 2026, an estimated $43.3K.
- Aurinia Pharmaceuticals made up ﹤0.01% of SEI Investments's portfolio in Q2 2026, its #2740 holding.
- SEI Investments first reported a position in Aurinia Pharmaceuticals in Q3 2025 and has held it in 4 quarters since.
- SEI Investments's Aurinia Pharmaceuticals position peaked at $480K in Q3 2025.
- 282 funds tracked by Wall St. Rank held Aurinia Pharmaceuticals as of Q2 2026.
Based on SEI Investments's 13F filing for Q2 2026, filed 14 Aug 2026.